BlackRock, Inc. 13D and 13G filings for Evolent Health, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-26 11:50 am Purchase | 2023-12-31 | 13G | Evolent Health, Inc. EVH | BlackRock Inc. BLK | 8,423,999 7.300% | 722,080 (+9.38%) | Filing |
| 2023-01-31 1:58 pm Purchase | 2022-12-31 | 13G | Evolent Health, Inc. EVH | BlackRock Inc. BLK | 7,701,919 7.600% | 1,811,956 (+30.76%) | Filing |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | Evolent Health, Inc. EVH | BlackRock Inc. BLK | 5,889,963 6.600% | 287,730 (+5.14%) | Filing |
| 2021-01-29 09:57 am Sale | 2020-12-31 | 13G | Evolent Health, Inc. EVH | BlackRock Inc. BLK | 5,602,233 6.500% | -766,106 (-12.03%) | Filing |